Phase I Study of sss40 Injection for Moderate-to-Severe Bone Metastatic Cancer Pain

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Phase I Study of sss40 Injection for Moderate-to-Severe Bone Metastatic Cancer Pain	Cancer Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms	Recruiting	Phase 1 / Phase 2	2025-06-06		NCT07008703

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Shenyang Sunshine Pharmaceutical Co., LTD.	22

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Henan Cancer Hospital	Zhengzhou	China	67

Clinical trials